CIDRAP newsletters options
Pre-Hajj survey finds that at-risk French pilgrims aren't cancelling plans because of MERS.
The USDA told Foster Farms it will block plant operations if the company doesn't take quick action.
Discovery of the first new botulinum toxin in 40 years is coupled with withholding key data for security reasons.
Texas researchers have found evidence of 47 cases of dengue infection after testing 3,768 clinical specimens from Houston-area patients suspected of having a mosquito-borne viral disease from 2003 through 2005, according to their findings published yesterday in Vector-Borne and Zoonotic Diseases.
More on the current outbreak, including that DNA footprints match those of Salmonella outbreak earlier this year.
A German research team that analyzed and compared H7N9 influenza virus from a diseased human and H7 viruses from birds found that the human strain replicated as well as seasonal flu in lab culture designed to mimic human lung tissue, but the avian H7 strain grew poorly. They reported their findings yesterday in the latest edition of mBio.
In a randomized controlled trial in France, a statin drug failed to improve survival rates in patients with ventilator-associated pneumonia (VAP), according to a report published online today by the Journal of the American Medical Association (JAMA).
Multistate outbreak affecting hundreds highlights public health consequences of fed shutdown.
At a malaria conference in South Africa today, researchers reported more promising findings for a vaccine that is furthest along in development, and GlaxoSmithKline (GSK) officials said they now intend to submit a regulatory application for it to the European Medicines Agency (EMA) in 2014, according to a company press release.
Wearing gowns and gloves in all ICU rooms didn't lower the combined levels of two key drug-resistant threats significantly.
Indonesia's Ministry of Health has confirmed the country's second H5N1 case this year, in a 28-year-old man from Bekasi.
The man died from the disease, according to a machine-translated health ministry statement today on FluTrackers, the Web-based infectious disease message board. The health ministry statement is dated Oct 3.
The cases, apparently previously reported by Saudi Arabia, raise the global count to 136, with 58 deaths.
A vaccine targeting two common norovirus strains reduced vomiting and diarrhea and prevented severe illness in a small clinical challenge study, researchers reported today at the IDWeek conference in San Francisco.
The rate of needless antibiotic prescribing for the two conditions has stayed level for years.
Neither the seasonal trivalent (three-strain) influenza vaccine (TIV) nor a monovalent H3N2 vaccine substantially reduced shedding of variant H3N2 (H3N2v) virus in ferrets, but previous infection with a seasonal H3N2 virus did, according to a study yesterday in the Journal of Virology.
A two-drug combination may be effective against Middle East respiratory syndrome coronavirus (MERS-CoV), according to the results of a cell-culture study published today in the Journal of Infection.
New federal contracts establish a "fill and finish" network for flu vaccine to boost capacity by 20%.
Researchers who used a sophisticated modeling approach incorporating H7N9 case data from China found hints that the virus has low transmission potential and that the pace of infection slowed in April after officials closed live-bird markets.
The World Health Organization (WHO) and other health groups yesterday launched what they billed as the first global action plan to stop tuberculosis (TB) in children, saying it could save as many as 74,000 lives each year.
Response to seasonal flu, H7N9, MERS, and other threats could be markedly diminished.
